NCT04218864

Brief Summary

The objective of this study is to test whether the innovative intervention, "Strength for U in Relationship Empowerment" (SURE), reduces the frequency of IPV more than an attention, time, and information matched control condition in perinatal women seeking mental health care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 5, 2019

Completed
28 days until next milestone

Study Start

First participant enrolled

January 2, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 6, 2020

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 9, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 9, 2024

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

August 1, 2025

Completed
Last Updated

August 1, 2025

Status Verified

July 1, 2025

Enrollment Period

4.1 years

First QC Date

December 5, 2019

Results QC Date

May 21, 2025

Last Update Submit

July 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Composite Abuse Scale (CAS)

    The frequency of IPV will be measured using the Composite Abuse Scale. The Composite Abuse Scale is a 30-item scale with 4 subscales that measure severe combined abuse, emotional abuse, physical abuse, and harassment. Items are scored between 0 and 5, with Never=0 and Daily=5. Scale range is from 0-150. The lower the score, the better or less victimization. Change scores will be used to estimate differences within and between groups.

    Baseline, 6-week follow-up, 3, 6, and 12-month follow-up.

Secondary Outcomes (2)

  • The Positive Affect and Well-being Scale (PAW)

    Baseline, 6-week follow-up, 3, 6, and 12-month follow-up

  • Perceived Emotional Support (PES)

    Baseline, 6-week follow-up, 3, 6, and 12-month follow-up

Other Outcomes (2)

  • Personal Progress Scale-Revised (PPS-R)

    Baseline, 6-week follow-up, 3, 6, and 12-month follow-up

  • Self-efficacy (GSE)

    Baseline, 6-week follow-up, 3, 6, and 12-month follow-up

Study Arms (2)

Strength for U in Relationship Empowerment (SURE)

EXPERIMENTAL

Theory-driven and derived from empirical support

Behavioral: Strength for U in Relationship Empowerment (SURE)

Attention, time, and information matched control

ACTIVE COMPARATOR

Well-validated

Behavioral: Attention, time, and information matched control

Interventions

A brief computer-based intervention (one session plus one booster session) based on motivational interviewing.

Strength for U in Relationship Empowerment (SURE)

A brief computer based intervention (one session plus booster session) that involves viewing of popular television shows

Attention, time, and information matched control

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women
  • Women who have had a baby in the last 12 months
  • Between the ages of 18-45 years old
  • Have reported partner abuse within the last year as measured by the Woman Abuse Screening Tool (WAST)
  • Have sought mental health treatment

You may not qualify if:

  • Cannot provide informed consent
  • Unable to understand English
  • No access to the internet or a device with internet access
  • Discomfort with internet use
  • No privacy to view a 40-minute online intervention
  • Screen positive for risk of intimate partner violence that involves severe injury or homicide
  • Screen positive for risk of spyware/stalkerware
  • At one of the two research site, study recruit is unwilling to meet for in-person study visits (if criteria 3-8 are met)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Women and Infants Hospital of Rhode Island

Providence, Rhode Island, 02905, United States

Location

MeSH Terms

Conditions

Psychological Well-Being

Interventions

Time

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Intervention Hierarchy (Ancestors)

Physical Phenomena

Results Point of Contact

Title
Dr. Caron Zlotnick
Organization
Women & Infants Hospital

Study Officials

  • Caron Zlotnick, PhD

    Women and Infants Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Psychiatry and Human Behavior, Professor of Obstetrics and Gynecology, Professor of Medicine

Study Record Dates

First Submitted

December 5, 2019

First Posted

January 6, 2020

Study Start

January 2, 2020

Primary Completion

February 9, 2024

Study Completion

February 9, 2024

Last Updated

August 1, 2025

Results First Posted

August 1, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

The study team does not currently have a plan to share data. However, the team is currently in discussion about sharing data and will update the registration as needed.

Locations